NEW PATENTS FEB 2018

New patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018033631	MARIZOMIB	CELGENE	CANCER
2	WO-2018034901	ELAMIPRETIDE	STEALTH	Barth syndrome; Mitochondrial myopathy
3	WO-2018033866	SACUBITRIL, VALSARTAN	NOVARTIS	CARDIAC FAILURE, HYPERTENSION
4	WO-2018033149	OZANIMOD	CRYSTAL	Multiple sclerosis; Ulcerative colitis
5	WO-2018033139	SOFOSBUVIR	CHIA	Hepatitis C virus infection
6	WO-2018032521	LIRAGLUTIDE	SHENZEN	Non-insulin dependent diabetes; Obesity
7	WO-2018032356	SOFOSBUVIR	PHARMARESOURCES	Hepatitis C virus infection
8	WO-2018032796	SITAFLOXACIN	CHEN-STONE	Bacterial infection
9	WO-2018033939	BUDESONIDE	ANANTCO	Allergic rhinitis; Inflammatory bowel disease; Irritable bowel syndrome

 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03281941	LESINURAD	ZENTIVA	Gout; Hyperuricemia
2	WO-2018029711	VENETOCLAX	MYLAN	Chronic lymphocytic leukemia
3	WO-2018029699	BELINIOSTAT	MSN	Hematological neoplasm; Solid tumor
4	WO-2018029264	DAPAGLIFLOZIN	AMNEAL	Non-insulin dependent diabetes
5	WO-2018029223	GALETERONE	INDUSTRIALE	PROSTRATE TUMOR
6	WO-2018028508	PIRFENIDONE	IND	Idiopathic pulmonary fibrosis
7	WO-2018028506	PIRFENIDONE	IND	Idiopathic pulmonary fibrosis
8	WO-2018029611	DAPAGLIFLOZIN	LAURUS	Non-insulin dependent diabetes
9	WO-2018028420	PLINABULIN	QUINGDAO	CANCER
10	WO-2018028679	MIRABEGRON	ZHEJIANG	Overactive bladder

FEB 05 2018, NEW PATENTS

FEB 052018

12 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018023009	LURASIDONE	CONCERT	Bipolar I disorder; Schizophrenia
2	WO-2018022704	SELEXIPAG	TEVA	Pulmonary artery hypertension
3	WO-2018021818	FEBUXOSTAT	HANMI	Gout; Hyperuricemia; Tumor lysis syndrome
4	WO-2018021517	AMISELIMOD	MITSUBISHI	Autoimmune disease; Crohns disease; Inflammatory bowel disease; Multiple sclerosis; Psoriasis
5	WO-2018020506	CANAGLIFLOZIN	NATCO	Non-insulin dependent diabetes
6	WO-2018020450	ELUXADOLINE	LUPIN	Diarrhea predominant irritable bowel syndrome
7	WO-2018020406	BELINOSTAT	FRASENIUS	CANCER
8	WO-2018020380	DOLUTEGRAVIR	LUPIN	HIV infection
9	WO-2018020366	TRANYLCYPROMINE	GSK	Depression; Parkinsons disease
10	WO-2018019549	OMACETAXINE	INDENA	Chronic myelocytic leukemia
11	WO-2018019196	IXAZOMIB	SHENZEN	CANCER
12	WO-2018018986	CERITINIB	ARROMAX	Cardiovascular disease; Infectious disease; Inflammatory disease; Metabolic disorder; Viral infection
13
14
15
16

Feb 01 NEW PATENTS

new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018015821	SOFOSBUVIR	OPTIMUS	Hepatitis C virus infection
2	WO-2018015974	SELEXIPAG	MYLAN	Pulmonary artery hypertension
3	WO-2018017153	VECABRUTINIB	BIOGEN	Autoimmune disease; Cancer; Inflammatory disease
4	WO-2018016795	BESIFOVIR	IL DONG	Hepatitis B virus infection
5	WO-2018015929	DARUNAVIR	GRANULES	HIV-1 infection
6	WO-2018015847	DACLATASVIR	GLENMARK	Hepatitis C virus infection
7	WO-2018015354	BREXPIPRAZOLE	ADAMED	Major depressive disorder; Schizophrenia
8	WO-2018014880	VORTIOXETINE	IND	Major depressive disorder
9	WO-2018014866	DAPAGLIFLOZIN	JIANGSU	Non-insulin dependent diabetes